-
Most Popular
Earnings Reports
DYN Stock Earnings: Dyne Therapeutics Beats EPS for Q2 2024
DYN stock results show that Dyne Therapeutics beat analyst estimates for earnings per share the second quarter of 2024.
MOBQ Stock Earnings: Mobiquity Technologies Reported Results for Q2 2024
Mobiquity Technologies just reported results for the second quarter of 2024.
IMMX Stock Earnings: Immix Biopharma Beats EPS for Q2 2024
IMMX stock results show that Immix Biopharma beat analyst estimates for earnings per share the second quarter of 2024.
EARN Stock Earnings: Ellington Credit Beats EPS, Misses Revenue for Q2 2024
EARN stock results show that Ellington Credit beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024.
LLAP Stock Earnings: Terran Orbital Beats EPS, Misses Revenue for Q2 2024
LLAP stock results show that Terran Orbital beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024.
XBP Stock Earnings: XBP Europe Holdings Reported Results for Q2 2024
XBP Europe Holdings just reported results for the second quarter of 2024.
XBIT Stock Earnings: XBiotech Reported Results for Q2 2024
XBiotech just reported results for the second quarter of 2024.
MULN Stock Earnings: Mullen Automotive Reported Results for Q3 2024
Mullen Automotive just reported results for the third quarter of 2024.
ATRA Stock Earnings: Atara Biotherapeutics Misses EPS, Misses Revenue for Q2 2024
ATRA stock results show that Atara Biotherapeutics missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024.
CALC Stock Earnings: CalciMedica Beats EPS for Q2 2024
CALC stock results show that CalciMedica beat analyst estimates for earnings per share the second quarter of 2024.
ADVM Stock Earnings: Adverum Biotechnologies Beats EPS for Q2 2024
ADVM stock results show that Adverum Biotechnologies beat analyst estimates for earnings per share the second quarter of 2024.
SPRB Stock Earnings: Spruce Biosciences Beats EPS, Beats Revenue for Q2 2024
SPRB stock results show that Spruce Biosciences beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
IMNM Stock Earnings: Immunome Misses EPS, Misses Revenue for Q2 2024
IMNM stock results show that Immunome missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024.
TXMD Stock Earnings: TherapeuticsMD Reported Results for Q2 2024
TherapeuticsMD just reported results for the second quarter of 2024.
AEON Stock Earnings: AEON Biopharma Beats EPS for Q2 2024
AEON stock results show that AEON Biopharma beat analyst estimates for earnings per share the second quarter of 2024.
PRSO Stock Earnings: Peraso Misses EPS, Beats Revenue for Q2 2024
PRSO stock results show that Peraso missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024.
SVRA Stock Earnings: Savara Misses EPS for Q2 2024
SVRA stock results show that Savara missed analyst estimates for earnings per share the second quarter of 2024.
ORIC Stock Earnings: ORIC Pharmaceuticals Misses EPS for Q2 2024
ORIC stock results show that ORIC Pharmaceuticals missed analyst estimates for earnings per share the second quarter of 2024.
SRZN Stock Earnings: Surrozen Misses EPS for Q2 2024
SRZN stock results show that Surrozen missed analyst estimates for earnings per share the second quarter of 2024.